SG49702A1 - Somatotropins with alterations in the alphahelix 1 region and combinations with other mutations - Google Patents
Somatotropins with alterations in the alphahelix 1 region and combinations with other mutationsInfo
- Publication number
- SG49702A1 SG49702A1 SG1996004237A SG1996004237A SG49702A1 SG 49702 A1 SG49702 A1 SG 49702A1 SG 1996004237 A SG1996004237 A SG 1996004237A SG 1996004237 A SG1996004237 A SG 1996004237A SG 49702 A1 SG49702 A1 SG 49702A1
- Authority
- SG
- Singapore
- Prior art keywords
- somatotropins
- helix
- alpha
- mutations
- combinations
- Prior art date
Links
- 230000035772 mutation Effects 0.000 title abstract 2
- 230000004075 alteration Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002741 site-directed mutagenesis Methods 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Battery Electrode And Active Subsutance (AREA)
- Mold Materials And Core Materials (AREA)
- Secondary Cells (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Medicines Containing Plant Substances (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62165690A | 1990-11-30 | 1990-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG49702A1 true SG49702A1 (en) | 1998-06-15 |
Family
ID=24491070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996004237A SG49702A1 (en) | 1990-11-30 | 1991-11-28 | Somatotropins with alterations in the alphahelix 1 region and combinations with other mutations |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5548068A (ja) |
| EP (1) | EP0496973B1 (ja) |
| JP (1) | JPH05105634A (ja) |
| KR (1) | KR100193005B1 (ja) |
| AT (1) | ATE163045T1 (ja) |
| CA (1) | CA2056467C (ja) |
| DE (1) | DE69128877T2 (ja) |
| DK (1) | DK0496973T3 (ja) |
| ES (1) | ES2112847T3 (ja) |
| FI (1) | FI104489B (ja) |
| GR (1) | GR3026761T3 (ja) |
| HU (1) | HU215947B (ja) |
| IE (1) | IE914153A1 (ja) |
| IL (1) | IL100169A0 (ja) |
| NO (1) | NO301235B1 (ja) |
| NZ (2) | NZ260103A (ja) |
| PT (1) | PT99648B (ja) |
| SG (1) | SG49702A1 (ja) |
| TW (1) | TW198040B (ja) |
| ZA (1) | ZA919453B (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6006079A (en) * | 1997-06-13 | 1999-12-21 | Motorola, Inc. | Radio having a fast adapting direct conversion receiver |
| TR200504220T2 (tr) * | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
| GB2389115B (en) * | 2001-12-14 | 2005-03-16 | Asterion Ltd | Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone |
| ATE466085T1 (de) * | 2002-09-09 | 2010-05-15 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
| US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
| MX2009004134A (es) | 2006-10-20 | 2009-08-12 | Biogen Idec Inc | Tratamiento de trastornos de desmielinizacion con el receptor de linfotoxina beta soluble. |
| US8338376B2 (en) | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| EP2709647B1 (en) * | 2011-02-23 | 2019-08-07 | Massachusetts Institute Of Technology | Water soluble membrane proteins and methods for the preparation and use thereof |
| US10373702B2 (en) | 2014-03-27 | 2019-08-06 | Massachusetts Institute Of Technology | Water-soluble trans-membrane proteins and methods for the preparation and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0355460B1 (en) * | 1988-08-24 | 2000-12-27 | American Cyanamid Company | Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization |
| WO1990004788A1 (en) * | 1988-10-28 | 1990-05-03 | Genentech, Inc. | Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
-
1991
- 1991-11-25 NZ NZ260103A patent/NZ260103A/en unknown
- 1991-11-25 NZ NZ240718A patent/NZ240718A/en unknown
- 1991-11-27 IL IL100169A patent/IL100169A0/xx unknown
- 1991-11-28 ES ES91120396T patent/ES2112847T3/es not_active Expired - Lifetime
- 1991-11-28 AT AT91120396T patent/ATE163045T1/de not_active IP Right Cessation
- 1991-11-28 SG SG1996004237A patent/SG49702A1/en unknown
- 1991-11-28 DE DE69128877T patent/DE69128877T2/de not_active Expired - Fee Related
- 1991-11-28 CA CA002056467A patent/CA2056467C/en not_active Expired - Fee Related
- 1991-11-28 DK DK91120396.6T patent/DK0496973T3/da active
- 1991-11-28 EP EP91120396A patent/EP0496973B1/en not_active Expired - Lifetime
- 1991-11-29 PT PT99648A patent/PT99648B/pt not_active IP Right Cessation
- 1991-11-29 JP JP3339516A patent/JPH05105634A/ja active Pending
- 1991-11-29 ZA ZA919453A patent/ZA919453B/xx unknown
- 1991-11-29 IE IE415391A patent/IE914153A1/en not_active Application Discontinuation
- 1991-11-29 FI FI915654A patent/FI104489B/fi active
- 1991-11-29 HU HU913723A patent/HU215947B/hu not_active IP Right Cessation
- 1991-11-29 NO NO914724A patent/NO301235B1/no not_active IP Right Cessation
- 1991-11-30 KR KR1019910021901A patent/KR100193005B1/ko not_active Expired - Fee Related
-
1992
- 1992-02-20 TW TW081101242A patent/TW198040B/zh active
-
1994
- 1994-12-23 US US08/363,982 patent/US5548068A/en not_active Expired - Fee Related
-
1998
- 1998-04-30 GR GR980400960T patent/GR3026761T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0496973B1 (en) | 1998-02-04 |
| NO914724D0 (no) | 1991-11-29 |
| ATE163045T1 (de) | 1998-02-15 |
| HUT62327A (en) | 1993-04-28 |
| AU662493B2 (en) | 1995-09-07 |
| IL100169A0 (en) | 1992-08-18 |
| EP0496973A3 (en) | 1993-02-24 |
| CA2056467A1 (en) | 1992-05-31 |
| PT99648B (pt) | 1999-05-31 |
| JPH05105634A (ja) | 1993-04-27 |
| ZA919453B (en) | 1992-08-26 |
| TW198040B (ja) | 1993-01-11 |
| DK0496973T3 (da) | 1998-05-04 |
| FI915654L (fi) | 1992-05-31 |
| IE914153A1 (en) | 1992-06-03 |
| KR920009413A (ko) | 1992-06-25 |
| FI104489B (fi) | 2000-02-15 |
| DE69128877T2 (de) | 1998-06-18 |
| KR100193005B1 (ko) | 1999-06-15 |
| HU215947B (hu) | 1999-03-29 |
| NO301235B1 (no) | 1997-09-29 |
| NZ260103A (en) | 1996-10-28 |
| ES2112847T3 (es) | 1998-04-16 |
| GR3026761T3 (en) | 1998-07-31 |
| CA2056467C (en) | 1998-07-07 |
| FI915654A0 (fi) | 1991-11-29 |
| NO914724L (no) | 1992-06-01 |
| AU8830091A (en) | 1992-06-04 |
| US5548068A (en) | 1996-08-20 |
| EP0496973A2 (en) | 1992-08-05 |
| HU913723D0 (en) | 1992-02-28 |
| DE69128877D1 (de) | 1998-03-12 |
| NZ240718A (en) | 1996-10-28 |
| PT99648A (pt) | 1992-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL274485A1 (en) | Method of obtaining stable preparations of human proteins | |
| EP0210189A4 (en) | RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN. | |
| AU5258898A (en) | Mutant forms of fas ligand and uses thereof | |
| DE69939330D1 (de) | Wachstumsfaktor-homologe zvegf-3 | |
| TW198040B (ja) | ||
| GB8727045D0 (en) | Immunoglobulin e competitor | |
| IL102346A0 (en) | Cysteine depleted il-6 muteins | |
| NO914720L (no) | Somatotropiner med forandringer i alfa-spiral-3-omraadet, alfa-spiral-2-omraadekombinasjoner derav og i kombinasjon medandre mutasjoner | |
| HUT61486A (en) | Implant composition comprising biologically active protein, peptide or polypeptide | |
| EP0315118A3 (en) | Dna coding for endothelin and use thereof | |
| ES2033212A6 (es) | Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados. | |
| EP0267795A3 (en) | Murine-interleukin-2 muteins | |
| EP0723016A3 (en) | Leukocyte activation factor | |
| DK411686A (da) | Peptider |